BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21472783)

  • 1. Formation of solid solutions between racemic and enantiomeric citalopram oxalate.
    de Diego HL; Bond AD; Dancer RJ
    Chirality; 2011 May; 23(5):408-16. PubMed ID: 21472783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
    Huang J; Chen S; Guzei IA; Yu L
    J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
    Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
    Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
    Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation.
    Choobdari E; Fakhraian H; Peyrovi MH
    Chirality; 2014 Mar; 26(3):183-8. PubMed ID: 24574075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations.
    Koldsø H; Severinsen K; Tran TT; Celik L; Jensen HH; Wiborg O; Schiøtt B; Sinning S
    J Am Chem Soc; 2010 Feb; 132(4):1311-22. PubMed ID: 20055463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential enrichment: full crystallographic analysis of the unusual phenomenon in the mixed crystals' version.
    Takahashi H; Tamura R; Fujimoto D; Lepp Z; Kobayashi K; Ushio T
    Chirality; 2002 Jul; 14(7):541-7. PubMed ID: 12112325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone.
    Wang XJ; Wiehler H; Ching CB
    Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physicochemical properties of suplatast tosilate racemate and enantiomers].
    Ushio T; Endo K; Yamamoto K
    Yakugaku Zasshi; 1996 Nov; 116(11):866-75. PubMed ID: 8981830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility properties of racemic praziquantel and its enantiomers.
    el-Arini SK; Giron D; Leuenberger H
    Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.
    Tanum L; Strand LP; Refsum H
    Pharmacopsychiatry; 2010 Jul; 43(5):190-3. PubMed ID: 20503148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of solid-state nature of 2-chloromandelic acid.
    He Q; Zhu J; Gomaa H; Jennings M; Rohani S
    J Pharm Sci; 2009 May; 98(5):1835-44. PubMed ID: 18837015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.
    Sidhu J; Priskorn M; Poulsen M; Segonzac A; Grollier G; Larsen F
    Chirality; 1997; 9(7):686-92. PubMed ID: 9366029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of molecular chirality on racemate stability: alpha-amino acids with nonpolar R groups.
    Huang J; Yu L
    J Am Chem Soc; 2006 Feb; 128(6):1873-8. PubMed ID: 16464087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal-driven distortion of ligands in copper coordination complexes: conformational pseudo-enantiomers.
    Xu X; Maresca KJ; Das D; Zahn S; Zubieta J; Canary JW
    Chemistry; 2002 Dec; 8(24):5679-83. PubMed ID: 12693049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
    Duddu SP; Grant DJ
    Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
    Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
    J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.